Cairo – Mubasher: The National Bank of Egypt (CBE) approved a EGP 250 million increase in the short-term credit facilities provided to Ibnsina Pharma.

The increased facilities will finance the company’s working capital when needed, according to a bourse disclosure on Sunday.

During the first six months of 2020, the company logged EGP 88.9 million in net profits, down from EGP 103.19 million in the year-ago period.